SEC Company Response from VivoSim Labs, INC. (VIVS) (CIK 0001497253) (VIVS) — Feb 20, 2020
VivoSim Labs, INC. (VIVS) (CIK 0001497253)
Date: Feb. 20, 2020 · CIK: 0001497253 · Accession: 0001193125-20-043672
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-235683
Letter
Re: Acceleration Request of Organovo Holdings, Inc.
ORGANOVO HOLDINGS, INC.
February 20, 2020
VIA EDGAR
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C.
Registration Statement on Form S-4, as amended
Filed on December 23, 2019 (File No. 333-235683)
Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Organovo Holdings, Inc. (the “Company”) hereby requests acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-235683), as amended (the “Registration Statement”), so that it may become effective at 9:00 a.m. Eastern Time on February 24, 2020, or as soon as possible thereafter.
The Company hereby authorizes Jeff Thacker, Esq. of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
The Company respectfully requests that it be notified of such effectiveness by a telephone call to Attorney Thacker at (858) 436-8064 and that such effectiveness also be confirmed in writing. Any questions regarding this request may be addressed to Attorney Thacker.
Very truly yours,
ORGANOVO HOLDINGS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP ORGANOVO HOLDINGS, INC. February 20, 2020 VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Acceleration Request of Organovo Holdings, Inc. Registration Statement on Form S-4, as amended Filed on December 23, 2019 (File No. 333-235683) Ladies and Gentlemen: In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Organovo Holdings, Inc. (the “Company”) hereby requests acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-235683), as amended (the “Registration Statement”), so that it may become effective at 9:00 a.m. Eastern Time on February 24, 2020, or as soon as possible thereafter. The Company hereby authorizes Jeff Thacker, Esq. of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. The Company respectfully requests that it be notified of such effectiveness by a telephone call to Attorney Thacker at (858) 436-8064 and that such effectiveness also be confirmed in writing. Any questions regarding this request may be addressed to Attorney Thacker. Very truly yours, ORGANOVO HOLDINGS, INC. /s/ Taylor Crouch Taylor Crouch President and Chief Executive Officer cc: Craig Kussman Jennifer Bush Organovo Holdings, Inc. Jeffrey C. Thacker Jeffrey R. Vetter Ryan J. Gunderson Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP Andrew J. Fromkin Tarveda Therapeutics, Inc. Miguel J. Vega Marianne C. Sarrazin Cooley LLP